|Bid||0.15 x 800|
|Ask||32.77 x 1300|
|Day's Range||28.83 - 29.48|
|52 Week Range||23.55 - 68.19|
|Beta (5Y Monthly)||1.31|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 05, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||38.33|
Let's see if ANI Pharmaceuticals (ANIP) stock is a good choice for value-oriented investors right now from multiple angles.
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...
At this time, I would like to welcome everyone to the ANI Pharmaceuticals Third Quarter 2020 Earnings Results Conference Call. It is now my pleasure to turn the floor over to Ms. Lisa Wilson, Investor Relations for ANI Pharmaceuticals. This is Lisa Wilson of In-Site Communications, Investor Relations for ANI.